# Hydrochlorothiazide

NDC: 0228-2820
Generic name: Hydrochlorothiazide
Labeler / Manufacturer: Actavis Pharma, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET
Routes: ORAL
Marketing started: 20070312
Marketing ended: 20270630
FDA application: ANDA040707

## Active ingredients

- HYDROCHLOROTHIAZIDE: 12.5 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0228-2820"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0228-2820
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=afdf1170-25a0-496d-b293-36ee0db2cd1e